Argenx Shares Soar on Successful Vyvgart Drug Trial

Shares of Argenx SE jumped significantly following the European biotech company's announcement of another large, successful trial for its blockbuster autoimmune drug, Vyvgart.

17 Aug, 08:03 — 17 Aug, 08:03

Post Share

Sources

Showing 1 of 1 sources

bloombergHigh14d ago

Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart

Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart.

By Naomi Kresge

Read full article →

Argenx Shares Soar on Successful Vyvgart Drug Trial

Sources

Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart

Related Stories

UK Shop Price Inflation Hits Two-Year High After Energy Spike

U.S. Strikes on Iran Push Crude Oil Prices Above $90 a Barrel

Shein Prices Hong Kong IPO Below Range, Raising $1.74 Billion

Trump Administration Advances Venezuela Oil Talks and Drug Pricing Deals